(41) performed selective silencing of SHP-2 in HCC cells, which significantly increased phosphorylation of STAT3 induced by IL-6, thus promoting the transduction of the IL-6/STAT3 signaling pathway. Here, IL6 is linked to hepatocellular carcinoma.